Marketing Strategy News
- Eli Lilly: further Zyprexa Adhera delays benefit Johnson & Johnson Friday, January 9, 2009 @ 6:39PMFollowing the FDAs complete response letter for the drug, Eli Lilly has begun preparing a proposed risk evaluation mitigation strategy for Zyprexa Adhera. After the regulators previous non-approval letter requesting more information regarding adverse effects in clinical trials, this further delay plays into the hands of Johnson & Johnsons direct competitor product paliperidone palmitate.
- Asahi Beer Sales to Rise in Face of ‘Severe Market’ (Update1) Friday, January 9, 2009 @ 6:06PMJan. 9 (Bloomberg) -- Asahi Breweries Ltd., Japan’s top- selling beermaker, said sales by volume of beer and beer-like beverages will probably increase 0.8 percent this year.
- Achillion names new head of business development Friday, January 9, 2009 @ 5:56PMAchillion Pharmaceuticals, a developer of small molecule drugs, has appointed Joseph Truitt as its new vice president of business development and chief commercial officer.
- Addax Petroleum Announces Update to Gabon Drilling Program Friday, January 9, 2009 @ 5:51PMCALGARY, Canada, January 9 /PRNewswire/ -- - Successful Appraisal and Development Wells in Etame Marin License Area Addax Petroleum Corporation ("Addax Petroleum" or the "Corporation") (TSX:AXC and LSE:AXC) today announces the successful appraisal and development of the Ebouri field in the Etame Marin license area offshore Gabon.
- Addax Petroleum Announces Update to Gabon Drilling Program Friday, January 9, 2009 @ 5:44PM -